Literature DB >> 10092479

Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei.

L Troeberg1, R E Morty, R N Pike, J D Lonsdale-Eccles, J T Palmer, J H McKerrow, T H Coetzer.   

Abstract

Trypanosoma brucei brucei is a causative agent of bovine trypanosomiasis (nagana), a disease of considerable economic significance in much of Africa. Here we report investigations on the effects of various irreversible cysteine proteinase inhibitors, including vinyl sulfones (VS), peptidyl chloromethylketones (CMK), diazomethylketones, and fluoromethyl ketones, on the major lysosomal cysteine proteinase (trypanopain-Tb) of T. b. brucei and on in vitro-cultured bloodstream forms of the parasite. Many of the tested inhibitors were trypanocidal at low micromolar concentrations. Methylpiperazine urea-Phe-homoPhe-VS was the most effective trypanocidal agent, killing 50% of test populations at a work ing concentration of 0.11 microM, while carbobenzoxy-Phe-Phe-CMK was the most trypanocidal of the methylketones with an IC50 of 3.6 microM. Labelling of live and lysed T. b. brucei with biotinylated inhibitor derivatives suggests that trypanopain-Tb is the likely intracellular target for these inhibitors. Kinetic analysis of the inhibition of purified trypanopain-Tb by the inhibitors showed that most had kass values in the 10(6) M-1 s-1 range. We conclude that cysteine proteinase inhibitors have potential as trypanocidal agents and that a major target of these compounds is the lysosomal enzyme trypanopain-Tb. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092479     DOI: 10.1006/expr.1998.4386

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  12 in total

1.  Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease.

Authors:  Olga V Nikolskaia; Ana Paula C de A Lima; Yuri V Kim; John D Lonsdale-Eccles; Toshihide Fukuma; Julio Scharfstein; Dennis J Grab
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

2.  Multiple effects of pepstatin A on Trypanosoma cruzi epimastigote forms.

Authors:  Leandro S Sangenito; Keyla C Gonçalves; Erika A Abi-Chacra; Cátia L Sodré; Claudia M d'Avila-Levy; Marta H Branquinha; André L S Santos
Journal:  Parasitol Res       Date:  2011-12-29       Impact factor: 2.289

3.  Trypanocidal and cysteine protease inhibitory activity of isopentyl caffeate is not linked in Trypanosoma brucei.

Authors:  Dietmar Steverding; Flávio Rogério da Nóbrega; Stuart A Rushworth; Damião Pergentino de Sousa
Journal:  Parasitol Res       Date:  2016-08-18       Impact factor: 2.289

4.  Partial biochemical characterization of a metalloproteinase from the bloodstream forms of Trypanosoma brucei brucei parasites.

Authors:  Karina Pires de Sousa; Jorge Atouguia; Marcelo Sousa Silva
Journal:  Protein J       Date:  2010-05       Impact factor: 2.371

5.  α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPB.

Authors:  Koen Steert; Maya Berg; Jeremy C Mottram; Gareth D Westrop; Graham H Coombs; Paul Cos; Louis Maes; Jurgen Joossens; Pieter Van der Veken; Achiel Haemers; Koen Augustyns
Journal:  ChemMedChem       Date:  2010-10-04       Impact factor: 3.466

6.  Structure-guided development of selective TbcatB inhibitors.

Authors:  Jeremy P Mallari; Anang A Shelat; Aaron Kosinski; Conor R Caffrey; Michele Connelly; Fangyi Zhu; James H McKerrow; R Kiplin Guy
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

7.  Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.

Authors:  Jeremy P Mallari; Anang Shelat; Aaron Kosinski; Conor R Caffrey; Michele Connelly; Fangyi Zhu; James H McKerrow; R Kiplin Guy
Journal:  Bioorg Med Chem Lett       Date:  2008-04-08       Impact factor: 2.823

8.  Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent.

Authors:  Huaisheng Zhang; Jasmine Collins; Rogers Nyamwihura; Shelbi Ware; Marcel Kaiser; Ifedayo Victor Ogungbe
Journal:  Bioorg Med Chem Lett       Date:  2018-03-24       Impact factor: 2.823

9.  RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model.

Authors:  Maha-Hamadien Abdulla; Theresa O'Brien; Zachary B Mackey; Mohamed Sajid; Dennis J Grab; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24

10.  Role of the Trypanosoma brucei natural cysteine peptidase inhibitor ICP in differentiation and virulence.

Authors:  Camila C Santos; Graham H Coombs; Ana Paula C A Lima; Jeremy C Mottram
Journal:  Mol Microbiol       Date:  2007-10-17       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.